Adial Pharmaceuticals Inc. (ADIL) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Adial Pharmaceuticals Inc...

    NASDAQ: ADIL · Real-Time Price · USD
    0.47
    -0.14 (-22.46%)
    At close: Jul 30, 2025, 3:59 PM

    Adial Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 565.00 564.00 60.5K 55.11K
    Gross Profit
    		 n/a -564 -60.5K -55.11K
    Operating Income
    		 -8.28M -6.89M -13.32M -19.29M
    Interest Income
    		 178.66K 69.78K 63.34K 6.54K
    Pretax Income
    		 -13.2M -7M -12.73M -19.52M
    Net Income
    		 -13.2M -7M -12.73M -19.42M
    Selling & General & Admin
    		 5.06M 5.62M 9.14M 9.34M
    Research & Development
    		 3.23M 1.27M 4.18M 8.4M
    Other Expenses
    		 n/a -0.00 n/a 46.49K
    Operating Expenses
    		 8.28M 6.89M 13.32M 17.74M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 n/a 6.89M 13.32M 17.74M
    Income Tax Expense
    		 n/a n/a -502 -94.08K
    Shares Outstanding (Basic)
    		 18.59M 1.42M 1.06M 743.55K
    Shares Outstanding (Diluted)
    		 18.59M 1.42M 1.06M 743.55K
    EPS (Basic)
    		 -0.71 -4.92 -11.98 -26.12
    EPS (Diluted)
    		 -0.71 -4.91 -11.98 -26.12
    EBITDA
    		 -13.2M -7M -13.32M -19.46M
    EBIT
    		 -13.2M -7M -10.27M -19.52M
    Depreciation & Amortization
    		 565.00 564.00 564.00 55.11K

    Add to Watchlist